Legal & General Group PLC Fortress Biotech, Inc. Transaction History

Legal & General Group PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.79 - $22.0 $4,584 - $127,666	-5,803 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$0.8 - $1.5 $1,733 - $3,250	-2,167 Reduced 27.19%	5,803 $5,000
Q1 2022 May 16, 2022	BUY	$1.24 - $2.75 $574 - $1,273	463 Added 6.17%	7,970 $11,000
Q2 2021 Aug 12, 2021	BUY	$3.5 - $5.48 $2,397 - $3,753	685 Added 10.04%	7,507 $27,000
Q1 2021 May 17, 2021	SELL	$3.16 - $4.89 $119,274 - $184,573	-37,745 Reduced 84.69%	6,822 $24,000
Q4 2020 Feb 12, 2021	BUY	$2.2 - $4.45 $81,980 - $165,824	37,264 Added 510.26%	44,567 $141,000
Q3 2020 Nov 13, 2020	SELL	$2.62 - $4.78 $5,868 - $10,707	-2,240 Reduced 23.47%	7,303 $30,000
Q2 2020 Aug 14, 2020	BUY	$1.83 - $3.16 $17,463 - $30,155	9,543 New	9,543 $26,000
Q3 2019 Nov 13, 2019	SELL	$1.26 - $1.96 $6,288 - $9,782	-4,991 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$3.26 - $4.84 $16,270 - $24,156	4,991	4,991 $20,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $189M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.